文献速递主动脉外科食管与纵隔外科

德国三级主动脉与食管中心的多学科治疗主动脉食管瘘经验

Treatment of Aorto-Oesophageal Fistula in a Tertiary German Aortic and Oesophageal Centre A Multidisciplinary Effort.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2025-01-01

该回顾性分析纳入2014–2023年治疗的10例主动脉食管瘘患者,4例原发、6例TEVAR术后继发,初始TEVAR/再衬里7例,食管手术6例;总体30天死亡率40%,中位生存7.5个月;接受食管手术者生存长于未手术者(12.8个月 vs 0.35个月)。

要点

  • TEVAR可有效稳定初始出血,但单纯介入治疗不足。
  • 短间隔食管切除术可能改善生存,多数患者应考虑。
  • 牛心包开放主动脉置换是可行选项。

核心结论

  • TEVAR对初始出血稳定有效,但介入治疗 alone 不充分。
  • 短间隔食管切除术似乎改善生存,应多数患者考虑。
  • 牛心包开放主动脉置换是可行选项。

研究设计与样本

  • 回顾性分析2014–2023年治疗的主动脉食管瘘患者10例。
  • 主要终点为30天死亡率和中位生存,按病因和治疗策略亚组分析。
  • 系统检索近10年≥5例患者的研究。

主要发现

  • 10例中4例原发瘘,6例TEVAR术后继发,中位 manifestation 时间20.1个月(34.1)。
  • 初始TEVAR或再衬里7例,牛心包开放主动脉置换1例,部分牛心包补片修复2例。
  • 食管治疗:一期缝合1例,食管切除5例(胃上提或结肠代食管)。
  • 总体30天死亡率40%,中位生存7.5个月(12.8)。
  • 食管手术者中位生存12.8个月(4.7),未手术者0.35个月(0.4)。

临床怎么用

  • TEVAR用于稳定初始出血,但不应仅行介入治疗。
  • 多数患者应考虑短间隔食管切除术以改善生存。
  • 开放主动脉置换可选用牛心包材料。

局限性

  • 回顾性分析,样本量仅10例。
  • 缺乏前瞻性研究或大型病例系列,无循证治疗概念。
  • 文献中手术策略和患者特征差异大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Although rare, aorto-oesophageal fistula remains one of the most critical diseases in cardiovascular surgery. The lack of prospective studies or large case series leads to an absence of evidence-based therapeutic concepts. METHODS: We conducted a retrospective analysis of patients treated for aorto-oesophageal fistula between 2014 and 2023. Primary endpoints of analysis were 30-day mortality and median survival; subgroup analysis was performed for aetiology as well as treatment strategy. Additionally, a systematic search was conducted for all studies researching treatment of the disease, including ≥5 patients and published within the last 10 years. RESULTS: In the collective of 10 patients, 4 manifested as primary fistula, while in 6 patients the fistula occurred secondary to previous thoracic endovascular aortic repair. Median duration to manifestation post-TEVAR was 20.1 months (34.1). Initial treatment consisted of TEVAR or TEVAR-relining in 7 cases, followed by bovine open aortic replacement (n = 1) or partial bovine patch repair (n = 2) when viable. Treatment of the oesophagus consisted of primary suture (n = 1) or oesophagectomy (n = 5) with gastric pull-up or colon interposition. Overall 30-day mortality was 40%, and overall median survival was 7.5 months (12.8). Patients receiving surgical treatment of the oesophagus exhibited longer survival than patients who did not (12.8 months [4.7] vs 0.35 months [0.4]). Across the reviewed literature, the strongest effect on survival originates from surgical treatment of the oesophagus. Specific surgical strategies as well as patient characteristics vary widely. CONCLUSIONS: We found TEVAR effective in stabilizing the initial haemorrhage. Short-interval oesophagectomy seems to improve survival and should be considered in most patients. Open aortic replacement with bovine pericardium is a viable option. Interventional treatment options alone do not appear to be sufficient.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Strobl F, Stana J, Böhm AK, et al. Treatment of Aorto-Oesophageal Fistula in a Tertiary German Aortic and Oesophageal Centre A Multidisciplinary Effort. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 41105160. doi:10.1093/icvts/ivaf236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。